FindTrial
Sign In

Development and application of accurate diagnosis and treatment integration platform for navigation puncture based on DSA and radiofrequency ablation

Development and application of accurate diagnosis and treatment integration platform for navigation puncture based on DSA and radiofrequency ablation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-16009448
Enrollment
Unknown
Registered
2016-10-16
Start date
2016-12-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver tumors

Interventions

the experimental group:radiofrequency ablation is assisted by CT-like function base on DSA of domestic puncture navigation system and radiofrequency ablation treatment planning system
control group:Conventional radiofrequency ablation is assisted by CT-like function base on DSA of route-guidance

Sponsors

Shanghai Pubilc Health Clinical Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Liver tumor patients aged 18-80 years; 2. Male or female; 3. According to the related clinical guide line,the patient is willing to accept the radiofrequency ablation.

Exclusion criteria

Exclusion criteria: 1. There are contraindications by percutaneous puncture; 2. There are contraindications by liver tumor radiofrequency ablation.

Design outcomes

Primary

MeasureTime frame
Puncture accuracy;Tumor complete ablation rate;—

Secondary

MeasureTime frame
operation time;Complication rate;Operation convenience;Platform stability;—

Countries

China

Contacts

Public ContactYuan Min

Shanghai Pubilc Health Clinical Center

yuanmin@shphc.org.cn+86 18930817599

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026